黄芪佐治慢性肺源性心脏病及血液流变学观察

Observation of effects of Astragalus injection on Chronic Obstructive Pulmonary Disease and homorreology

目的 :观察黄芪注射液佐治慢性肺源性心脏病的疗效及血液流变学变化。方法 :对照组应用吸氧、抗感染、平喘、强心、利尿对症支持等内科综合治疗 ;治疗组在以上的基础上加用 5 %葡萄糖液 2 5 0 m L加黄芪 40 m L静脉点滴 ,每天 1次 ,两组均 7天为 1疗程。结果 :治疗组总有效率和显效率分别为 93.3%,70 .0 %;对照组总有效率和显效率分别为 70 .0 %,33.3%。两组间呈显著性差异 ( P<0 .0 5 )。两组血液流变学各项指标改善和心电图 ST-T改变好转率比较也有显著性差异( P<0 .0 5 )。结论 :黄芪注射液是治疗慢性肺源性心脏病较理想的佐治药物。

Objective: It is to observe the effects of Astragalus injection on Chronic Obstructive Pulmonary Disease(COPD) and the changes of homorreology. Methods: The control group used medical treatment such as oxygenation, antimicrobial therapy, diuresis and vasodilation. At the basis of the above, the therapy group was given 5% glucose injection 250mL and Astragalus injection 40mL intravenously once a day for a week. Results: The total effective rate and obviously effective rate of therapy group were 93.3% and 70.0%, and those of control group were 70.0% and 33.3%. There was significantly difference between the two groups(P<0.05). The parameters of hemorrheology and ECG(ST-T) in the therapy group were improved markedly and they compared significantly with those in the control group. Conclusion: Astragalus injection is a good drug to be used to treat patients with COPD.